about
Young at Heart: Pioneering Approaches to Model Nonischaemic Cardiomyopathy with Induced Pluripotent Stem CellsROS, Notch, and Wnt signaling pathways: crosstalk between three major regulators of cardiovascular biologyp62 binding to protein kinase C ζ regulates tumor necrosis factor α-induced apoptotic pathway in endothelial cellsPKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylationThioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2Cyclophilin A is required for angiotensin II-induced p47phox translocation to caveolae in vascular smooth muscle cells.Cyclophilin A: a key player for human diseaseAcetylation of cyclophilin A is required for its secretion and vascular cell activationFlow shear stress and atherosclerosis: a matter of site specificity.c-kit(+) cells: the tell-tale heart of cardiac regeneration?Peptidyl-prolyl isomerases: a full cast of critical actors in cardiovascular diseases.Cytotoxic furostanol saponins and a megastigmane glucoside from tribulus parvispinus.Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways.Antiproliferative and pro-apoptotic activity of novel phenolic derivatives of resveratrol.The mitochondrial lncRNA ASncmtRNA-2 is induced in aging and replicative senescence in Endothelial Cells.Cyclophilin A promotes cardiac hypertrophy in apolipoprotein E-deficient mice.Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation.Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms.Inhibition of the thioredoxin system is a basis for the antileukemic potential of 13-hydroxy-15-oxo-zoapatlin.13-Hydroxy-15-oxo-zoapatlin, an ent-kaurane diterpene, induces apoptosis in human leukemia cells, affecting thiol-mediated redox regulation.Cyclophilin A modulates bone marrow-derived CD117(+) cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis.Bone Marrow Cell Therapy for Ischemic Heart Disease: The Never Ending Story.Methylation profiling by bisulfite sequencing analysis of the mtDNA Non-Coding Region in replicative and senescent Endothelial Cells
P50
Q26750663-0AA3DCCE-0E42-45CC-A675-55165294E8CCQ28396460-7C0E03BE-CCC0-4DBA-9F05-1E33C42B1DA1Q33855169-52A95104-57DF-4770-8A39-1B6EEE7F42EFQ35018220-DE37B35C-E747-4C60-9309-989979C4446EQ35906034-7C9062D3-6CFB-4368-B41A-0E346455207AQ37280611-49C81CEB-E1E4-4596-A23E-01CBF7C65E9FQ37577487-951A354F-ACA4-4121-94E7-F83446928D7AQ37591224-1C9E2E8C-25FE-4270-98E1-9425DF54A8CCQ37807049-99A0A222-7A4E-41C0-B9CE-247D6EEAB5FAQ38313140-2BDC4B01-7A49-45FE-A4ED-900C0E80843EQ38370240-F1473CCD-7A8C-49F2-BDDE-308FD8250C5EQ39350801-99AC90BA-BEFF-409A-9B32-98BD679AC9D2Q39711130-63B36D3B-20AB-41C9-BB63-E3E26F466F20Q40086434-9F07FD7C-3B7B-4C46-B53A-1DE84FF743DDQ41498647-B291A03A-A1CB-4EE1-AAFA-EF31F4B2E8A5Q42043334-79ED0C79-BE6F-453C-908B-81E3D93497CEQ42628291-5B253F0A-46EC-442D-8756-35EB35571450Q43102272-0FD32E79-0140-485E-8E4F-22594B8D83DEQ46475147-82EBA846-2FD7-41AB-8749-B306CEE4B5EBQ46951217-2691F7E1-CA70-4BB3-AA60-810D99D5007BQ53127022-36E0B2FD-F228-4FF0-BC7B-0E600AC4B5DDQ54258496-571B0586-E486-4347-85F2-D7B8D26C0327Q61049755-C3906513-946A-4945-B70F-A0605F57991B
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Patrizia Nigro
@ast
Patrizia Nigro
@en
Patrizia Nigro
@es
Patrizia Nigro
@nl
Patrizia Nigro
@sl
type
label
Patrizia Nigro
@ast
Patrizia Nigro
@en
Patrizia Nigro
@es
Patrizia Nigro
@nl
Patrizia Nigro
@sl
prefLabel
Patrizia Nigro
@ast
Patrizia Nigro
@en
Patrizia Nigro
@es
Patrizia Nigro
@nl
Patrizia Nigro
@sl
P106
P1153
23991328500
P21
P31
P496
0000-0003-0182-4346